Markets:

Overview

News

Currencies

International

Treasuries

Sutro Biopharma, Inc. - Common Stock (NQ:STRO)

14.52 -0.61 (-4.03%)

Delayed Quote Updated: 2:07 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sutro Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket ↗

November 07, 2024

Via Benzinga

Peeling Back The Layers: Exploring Sutro Biopharma Through Analyst Insights ↗

October 11, 2024

Via Benzinga

Analyst Expectations For Sutro Biopharma's Future ↗

September 16, 2024

Via Benzinga

STRO Stock Earnings: Sutro Biopharma Beats EPS, Beats Revenue for Q2 2024 ↗

August 13, 2024

STRO stock results show that Sutro Biopharma beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 20, 2024

Via Benzinga

Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday ↗

May 20, 2024

Via Benzinga

STRO Stock Earnings: Sutro Biopharma Misses EPS, Beats Revenue for Q1 2024 ↗

May 13, 2024

STRO stock results show that Sutro Biopharma missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts ↗

May 08, 2024

Via Benzinga

What's Going On With Sutro Biopharma (STRO) Stock? ↗

April 02, 2024

Sutro Biopharma shares are trading lower by 4.3% during Tuesday's session. The company announced the pricing of an underwritten offering.

Via Benzinga

REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday ↗

March 28, 2024

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat...

Via Benzinga

Navigating 4 Analyst Ratings For Sutro Biopharma ↗

March 27, 2024

Via Benzinga

Expert Ratings for Sutro Biopharma ↗

November 15, 2023

Via Benzinga

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 28, 2024

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 26, 2024

Via Benzinga

STRO Stock Earnings: Sutro Biopharma Beats EPS, Beats Revenue for Q4 2023 ↗

March 25, 2024

STRO stock results show that Sutro Biopharma beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Where Sutro Biopharma Stands With Analysts ↗

October 23, 2023

Via Benzinga

5 Analysts Have This to Say About Sutro Biopharma ↗

October 06, 2023

Via Benzinga

Where Sutro Biopharma Stands With Analysts ↗

August 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 30, 2023

Via Benzinga

Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates

November 27, 2023

From Vaxcyte, Inc.

Via GlobeNewswire

Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside ↗

October 06, 2023

Oppenheimer initiated coverage on Sutro Biopharma Inc (NASDAQ: STRO), representing around 200% potential upside.

Via Benzinga

Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 18, 2023

Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility.

Via Benzinga

Sutro Biopharma Earnings Perspective: Return On Capital Employed ↗

April 03, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 ↗

October 06, 2023

Via Benzinga

Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday ↗

January 10, 2023

U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 21, 2023

During the session on Thursday, 461 stocks hit new 52-week lows.

Via Benzinga

6 Analysts Have This to Say About Sutro Biopharma ↗

June 12, 2023

Via Benzinga

Where Sutro Biopharma Stands With Analysts ↗

March 31, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 19, 2023

During Tuesday's session, 275 companies made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 11, 2023

During the Friday's sesion, 157 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sutro Biopharma, Inc. - Common Stock (NQ:STRO)

All News about Sutro Biopharma, Inc. - Common Stock

Starting at /week.